Primary Sjögren syndrome complicated by autoimmune hemolytic anemia and pure red cell aplasia

American Journal of the Medical Sciences

Volumn 334, Issue 6, 2007, Pages 493-496

  Assimakopoulos, Stelios F ^a   Michalopoulou, Sotiria ^a   Melachrinou, Maria ^a   Giannakoulas, Nikolaos ^a   Papakonstantinou, Christos ^a   Lekkou, Alexandra ^a   Gogos, Charalambos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Autoimmune hemolytic anemia; Pure red cell aplasia; Sj gren syndrome

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HEMOGLOBIN; HYDROXYCHLOROQUINE SULFATE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW BIOPSY; CASE REPORT; COMORBIDITY; CORTICOSTEROID THERAPY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; PURE RED CELL ANEMIA; RETICULOCYTE COUNT; SJOEGREN SYNDROME;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; RED-CELL APLASIA, PURE; SJOGREN'S SYNDROME;

EID: 37349105399     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318068b5fd     Document Type: Article

References (27)

1. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
2. Ramakrishna R, Chaudhuri K, Sturgess A, et al. Hematologic manifestations of primary Sjögren syndrome: a clinicopathological study. Q J Med 1992;83:547-54.
3. Butchko AR, Jordan JA. Comparison of three commercially available serologic assays used to detect human Parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J Clin Microbiol 2004;42:3191-5.
4. Darabi K, Abdel-Wahab O, Dzik WH. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 2006;46:741-53.
5. Young NS, Abkowitz JL, Luzzatto L. New insights into the pathophysiology of acquired cytopenias. Hematology (Am Soc Hematol Educ Program) 2000:18-38.
6. Zecca M, De Stefano P, Nobili B, et al. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood 2001;97:3995-7.
7. Robak T. Monoclonal antibodies in the treatment of autoimmune cytopenias. Eur J Haematol 2004;72:79-88.
8. Aoki A, Ohno S, Ueda A, et al. [Hematologic abnormalities of primary Sjögren syndrome]. Nihon Rinsho Meneki Gakkai Kaishi 2000;23:124-8.
9. Zittoun R, Debain P, James JM, et al. [Hematologic manifestations and complications in Sjögren syndrome (author's transl)]. Sem Hop 1978;54:1011-20.
10. Mavragani CP, Vlachaki E, Voulgarelis M. Pure red cell aplasia in a Sjögren syndrome/lupus erythematosus overlap patient. Am J Hematol 2003;72:259-62.
11. Fujiu K, Kanno R, Shio Y, et al. Triad of thymoma, myasthenia gravis and pure red cell aplasia combined with Sjögren syndrome. Jpn J Thorac Cardiovasc Surg 2004;52:345-8.
12. Schattner A, Shtalrid M, Berrebi A. Autoimmune hemolytic anemia preceding Sjögren syndrome. J Rheumatol 1983;10:482-4.
13. Boling EP, Wen J, Reveille JD, et al. Primary Sjögren syndrome and autoimmune hemolytic anemia in sisters: a family study. Am J Med 1983;74:1066-71.
14. Chen CY, Lu CL, Chiu CF, et al. Primary biliary cirrhosis associated with mixed type autoimmune hemolytic anemia and sicca syndrome: a case report and review of literature. Am J Gastroenterol 1997;92:1547-9.
15. Yamanouchi J, Yokota E, Yamauchi Y, et al. [A case of Sjögren syndrome associated with advanced hemolytic anemia caused by worsening autoimmune cholangiopathy]. Ryumachi 1998;38:595-9.
16. Schattner A, Friedman J, Klepfish A, et al. Immune cytopenias as the presenting finding in primary Sjögren syndrome. QJM 2000;93:825-9.
17. Kikawada M, Watanabe D, Kimura A, et al. Autoimmune hemolytic anemia in an elderly patient with primary Sjögren syndrome. Intern Med 2005;44:1312-5.
18. Hegde UM, Gordon-Smith EC, Worlledge SM. Reticulocytopenia and "absence" of red cell autoantibodies in immune hemolytic anaemia. Br Med J 1977;2:1444-7.
19. Ammus SS, Yunis AA. Acquired pure red cell aplasia. Am J Hematol 1987;24:311-26.
20. Thompson DF, Gales MA. Drug-induced pure red cell aplasia. Pharmacotherapy 1996;16:1002-8.
21. Bailey FA, Lilly M, Bertoli LF, et al. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum 1989;32:901-5.
22. Casadevall N, Dupuy E, Molho-Sabatier P, et al. Autoantibodies against erythropoietin in a patient with pure redcell aplasia. N Engl J Med 1996;334:630-3.
23. Mangan KF, Chikkappa G, Farley PC. T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. J Clin Invest 1982;70:1148-56.
24. Dessypris EN. The biology of pure red cell aplasia. Semin Hematol 1991;28:275-84.
25. Meyer RJ, Hoffman R, Zanjani ED. Autoimmune hemolytic anemia and periodic pure red cell aplasia in systemic lupus erythematosus. Am J Med 1978;65:342-5.
26. Greenberg J, Curtis-Cohen M, Gill FM, et al. Prolonged reticulocytopenia in autoimmune hemolytic anemia of childhood. J Pediatr 1980;5:784-6.
27. Freedman J, Cheng LM, Murray D, et al. An unusual autoimmune hemolytic anemia in a patient with immunoblastic sarcoma. Am J Hematol 1983;14:175-84.